{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:40:42Z","timestamp":1793500842184,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13011-017-0115-4","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T12:27:30Z","timestamp":1496924850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Adherence to methadone maintenance treatment and associated factors among patients in Vietnamese mountainside areas"],"prefix":"10.1186","volume":"12","author":[{"given":"Long Hoang","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong Thu Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong Lan Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bach Xuan","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl A.","family":"Latkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"issue":"1","key":"115_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/her\/13.1.87","volume":"13","author":"MC Shediac-Rizkallah","year":"1998","unstructured":"Shediac-Rizkallah MC, Bone LR. Planning for the sustainability of community-based health programs: conceptual frameworks and future directions for research, practice and policy. Health Educ Res. 1998;13(1):87\u2013108.","journal-title":"Health Educ Res"},{"issue":"4","key":"115_CR2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2471\/BLT.11.086850","volume":"89","author":"M Kermode","year":"2011","unstructured":"Kermode M, Crofts N, Kumar MS, Dorabjee J. Opioid substitution therapy in resource-poor settings. Bull World Health Organ. 2011;89(4):243.","journal-title":"Bull World Health Organ"},{"issue":"3","key":"115_CR3","first-page":"23","volume":"10","author":"G Herget","year":"2005","unstructured":"Herget G. Methadone and buprenorphine added to the WHO list of essential medicines. HIV AIDS Policy Law Rev. 2005;10(3):23\u20134.","journal-title":"HIV AIDS Policy Law Rev"},{"key":"115_CR4","doi-asserted-by":"crossref","unstructured":"Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, Mills S, et al. The cost-effectiveness and budget impact of Vietnam's methadone maintenance treatment programme in HIV prevention and treatment among injection drug users. Glob Public Health. 2012;7(10):1080\u201394.","DOI":"10.1080\/17441692.2012.736259"},{"key":"115_CR5","doi-asserted-by":"crossref","unstructured":"Tran BX, Ohinmaa A, Duong AT. Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics. Drug Alcohol Depend. 2012;125","DOI":"10.1016\/j.drugalcdep.2012.02.021"},{"issue":"1","key":"115_CR6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1037\/1064-1297.10.1.39","volume":"10","author":"MK Greenwald","year":"2002","unstructured":"Greenwald MK. Heroin craving and drug use in opioid-maintained volunteers: effects of methadone dose variations. Exp Clin Psychopharmacol. 2002;10(1):39\u201346.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"4","key":"115_CR7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00007691-200208000-00001","volume":"24","author":"K Wolff","year":"2002","unstructured":"Wolff K. Characterization of methadone overdose: clinical considerations and the scientific evidence. Ther Drug Monit. 2002;24(4):457\u201370.","journal-title":"Ther Drug Monit"},{"key":"115_CR8","doi-asserted-by":"crossref","unstructured":"Roux P, Lions C, Michel L, Cohen J, Mora M, Marcellin F, et al. Predictors of non-adherence to methadone maintenance treatment in opioid-dependent individuals: implications for clinicians. Curr Pharm Des. 2014;20(25):4097\u2013105.","DOI":"10.2174\/13816128113199990623"},{"key":"115_CR9","unstructured":"Health VMo. Decision No 3140\/QD-BYT on Guideline for Substance abuse treatment using methadone. Hanoi: Ministry of Health; 2010."},{"key":"115_CR10","doi-asserted-by":"crossref","unstructured":"Raffa JD, Grebely J, Tossonian H, Wong T, Viljoen M, Khara M, et al. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program. Drug Alcohol Depend. 89(2):306\u20139.","DOI":"10.1016\/j.drugalcdep.2007.02.007"},{"issue":"8","key":"115_CR11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1089\/apc.2006.0192","volume":"21","author":"GM Lucas","year":"2007","unstructured":"Lucas GM, Mullen BA, McCaul ME, Weidle PJ, Hader S, Moore RD. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. AIDS Patient Care STDs. 2007;21(8):564\u201374.","journal-title":"AIDS Patient Care STDs"},{"issue":"2","key":"115_CR12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jsat.2007.08.013","volume":"35","author":"M Haskew","year":"2008","unstructured":"Haskew M, Wolff K, Dunn J, Bearn J. Patterns of adherence to oral methadone: implications for prescribers. J Subst Abus Treat. 2008;35(2):109\u201315.","journal-title":"J Subst Abus Treat"},{"issue":"1","key":"115_CR13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/ADM.0000000000000263","volume":"11","author":"K Zhou","year":"2017","unstructured":"Zhou K, Li H, Wei X, Li X, Zhuang G. Medication Adherence in Patients Undergoing Methadone Maintenance Treatment in Xi'an, China. J Addict Med. 2017;11(1):28\u201333.","journal-title":"J Addict Med"},{"key":"115_CR14","doi-asserted-by":"crossref","unstructured":"Shen J, Wang M, Wang X, Zhang G, Guo J, Li X, et al. Predictors of poor adherence to methadone maintenance treatment in Yunnan Province, China. J Addict Med. 2016;10(1):40\u20135.","DOI":"10.1097\/ADM.0000000000000180"},{"key":"115_CR15","doi-asserted-by":"crossref","unstructured":"Hoang TV, Ha TTT, Hoang TM, Nhu NT, Quoc NC, Tam NM, et al. Impact of a methadone maintenance therapy pilot in Vietnam and its role in a scaled-up response. Harm reduction journal. 2015;12(1):39.","DOI":"10.1186\/s12954-015-0075-9"},{"issue":"4","key":"115_CR16","doi-asserted-by":"crossref","first-page":"e0123687","DOI":"10.1371\/journal.pone.0123687","volume":"10","author":"C-K Lin","year":"2015","unstructured":"Lin C-K, Hung C-C, Peng C-Y, Chao E, Lee TS-H. Factors associated with methadone treatment duration: a cox regression analysis. PLoS One. 2015;10(4):e0123687.","journal-title":"PLoS One"},{"key":"115_CR17","unstructured":"National Committee for AIDS DaPPaC. National Strategy on HIV\/AIDS Prevention and Control toward 2020 and the vision to 2030. Hanoi: the Vietnam Government; 2012."},{"key":"115_CR18","unstructured":"Control VAoHA. The annual review of HIV\/AIDS control and prevention in the first six months 2016 and action plan in the last six months in 2016. Hanoi: Ministry of Health; 2016."},{"issue":"3","key":"115_CR19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1345\/aph.1P587","volume":"45","author":"AB Kobin","year":"2011","unstructured":"Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother. 2011;45(3):372\u20139.","journal-title":"Ann Pharmacother"},{"key":"115_CR20","unstructured":"EQ-5D-5L User Guide: Basic information on how to use the EQ-5D-5L instrument. https:\/\/euroqol.org\/wp-content\/uploads\/2016\/09\/EQ-5D-5L_UserGuide_2015.pdf ."},{"key":"115_CR21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1477-7525-10-132","volume":"10","author":"BX Tran","year":"2012","unstructured":"Tran BX, Ohinmaa A, Nguyen LT. Quality of life profile and psychometric properties of the EQ-5D-5L in HIV\/AIDS patients. Health Qual Life Outcomes. 2012;10:132.","journal-title":"Health Qual Life Outcomes"},{"issue":"7","key":"115_CR22","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","volume":"31","author":"KA Bradley","year":"2007","unstructured":"Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31(7):1208\u201317.","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"115_CR23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/096228029900800102","volume":"8","author":"JL Schafer","year":"1999","unstructured":"Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999;8(1):3\u201315.","journal-title":"Stat Methods Med Res"},{"issue":"5","key":"115_CR24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1467-842X.2001.tb00294.x","volume":"25","author":"DA Bennett","year":"2001","unstructured":"Bennett DA. How can I deal with missing data in my study? Aust N Z J Public Health. 2001;25(5):464\u20139.","journal-title":"Aust N Z J Public Health"},{"issue":"3","key":"115_CR25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0740-5472(03)00029-1","volume":"24","author":"KH Wong","year":"2003","unstructured":"Wong KH, Lee SS, Lim WL, Low HK. Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users. J Subst Abus Treat. 2003;24(3):233\u20139.","journal-title":"J Subst Abus Treat"},{"key":"115_CR26","doi-asserted-by":"crossref","unstructured":"Yang F, Lin P, Li Y, He Q, Long Q, Fu X, et al. Predictors of retention in community-based methadone maintenance treatment program in Pearl River Delta, China. Harm reduction journal. 2013;10(1):3.","DOI":"10.1186\/1477-7517-10-3"},{"issue":"1","key":"115_CR27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.addbeh.2013.09.001","volume":"39","author":"K Zhou","year":"2014","unstructured":"Zhou K, Zhuang G. Retention in methadone maintenance treatment in mainland China, 2004\u20132012: A literature review. Addict Behav. 2014;39(1):22\u20139.","journal-title":"Addict Behav"},{"key":"115_CR28","doi-asserted-by":"crossref","unstructured":"Havens JR, Latkin CA, Pu M, Cornelius LJ, Bishai D, Huettner S, et al. Predictors of opiate agonist treatment retention among injection drug users referred from a needle exchange program. J Subst Abus Treat. 36(3):306\u201312.","DOI":"10.1016\/j.jsat.2008.07.002"},{"key":"115_CR29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12954-016-0091-4","volume":"13","author":"BX Tran","year":"2016","unstructured":"Tran BX, Nguyen LH, Nong VM, Nguyen CT, Phan HT, Latkin CA. Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam. Harm reduction journal. 2016;13:4.","journal-title":"Harm reduction journal"},{"issue":"3","key":"115_CR30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0376-8716(00)00148-4","volume":"61","author":"JS Cacciola","year":"2001","unstructured":"Cacciola JS, Alterman AI, Rutherford MJ, McKay JR, Mulvaney FD. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend. 2001;61(3):271\u201380.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"115_CR31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1477-7517-5-10","volume":"5","author":"V Wapf","year":"2008","unstructured":"Wapf V, Schaub M, Klaeusler B, Boesch L, Stohler R, Eich D. The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients. Harm Reduction Journal. 2008;5(1):10.","journal-title":"Harm Reduction Journal"},{"issue":"3","key":"115_CR32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/JCP.0b013e3181a39113","volume":"29","author":"AK Elkader","year":"2009","unstructured":"Elkader AK, Brands B, Selby P, Sproule BA. Methadone-Nicotine Interactions in Methadone Maintenance Treatment Patients. J Clin Psychopharmacol. 2009;29(3):231\u20138.","journal-title":"J Clin Psychopharmacol"},{"key":"115_CR33","doi-asserted-by":"crossref","unstructured":"Tran BX, Nguyen LH, Do HP, Nguyen NP, Phan HT, Dunne M, et al. Motivation for smoking cessation among drug-using smokers under methadone maintenance treatment in Vietnam. Harm reduction journal. 2015;12:50.","DOI":"10.1186\/s12954-015-0085-7"},{"issue":"11","key":"115_CR34","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1176\/appi.ps.55.11.1258","volume":"55","author":"KP Richter","year":"2004","unstructured":"Richter KP, Choi WS, McCool RM, Harris KJ, Ahluwalia JS. Smoking cessation services in U.S. methadone maintenance facilities. Psychiatric services (Washington, DC). 2004;55(11):1258\u201364.","journal-title":"Psychiatric services (Washington, DC)"},{"issue":"2","key":"115_CR35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1037\/1064-1297.15.2.144","volume":"15","author":"KP Richter","year":"2007","unstructured":"Richter KP, Hamilton AK, Hall S, Catley D, Cox LS, Grobe J. Patterns of smoking and methadone dose in drug treatment patients. Exp Clin Psychopharmacol. 2007;15(2):144\u201353.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"115_CR36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/pmed.1994.1009","volume":"23","author":"YI Hser","year":"1994","unstructured":"Hser YI, McCarthy WJ, Anglin MD. Tobacco Use as a Distal Predictor of Mortality Among Long-Term Narcotics Addicts. Prev Med. 1994;23(1):61\u20139.","journal-title":"Prev Med"},{"issue":"14","key":"115_CR37","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.1996.03530380039029","volume":"275","author":"RD Hurt","year":"1996","unstructured":"Hurt RD, Offord KP, Croghan IT, et al. Mortality following inpatient addictions treatment: Role of tobacco use in a community-based cohort. JAMA. 1996;275(14):1097\u2013103.","journal-title":"JAMA"},{"issue":"2","key":"115_CR38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1300\/J069v21n02_04","volume":"21","author":"WJ McCarthy","year":"2002","unstructured":"McCarthy WJ, Zhou Y, Hser YI, Collins C. To smoke or not to smoke: impact on disability, quality of life, and illicit drug use in baseline polydrug users. J Addict Dis. 2002;21(2):35\u201354.","journal-title":"J Addict Dis"},{"issue":"7","key":"115_CR39","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1007\/s10461-012-0271-5","volume":"16","author":"BX Tran","year":"2012","unstructured":"Tran BX, Houston S. Mobile phone-based antiretroviral adherence support in Vietnam: feasibility, patient's preference, and willingness-to-pay. AIDS Behav. 2012;16(7):1988\u201392.","journal-title":"AIDS Behav"},{"key":"115_CR40","doi-asserted-by":"crossref","unstructured":"Tran BX, Nguyen LT, Nguyen NH, Hoang QV, Hwang J. Determinants of antiretroviral treatment adherence among HIV\/AIDS patients: a multisite study. Glob Health Action. 2013;6","DOI":"10.3402\/gha.v6i0.19570"},{"key":"115_CR41","doi-asserted-by":"crossref","unstructured":"Latkin CA, Mai NV, Ha TV, Sripaipan T, Zelaya C, Le Minh N, et al. Social Desirability Response Bias and Other Factors That May Influence Self-Reports of Substance Use and HIV Risk Behaviors: A Qualitative Study of Drug Users in Vietnam. AIDS Educ Prev. 2016;28(5):417\u201325.","DOI":"10.1521\/aeap.2016.28.5.417"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-017-0115-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T19:27:38Z","timestamp":1569439658000},"score":1,"resource":{"primary":{"URL":"http:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-017-0115-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["115"],"URL":"https:\/\/doi.org\/10.1186\/s13011-017-0115-4","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,8]]},"article-number":"31"}}